Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal
Longer gap in Pfizer-BioNTech Covid vaccine boosts antibody levels: Study
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
World Coronavirus Dispatch: Asia's travel bubbles burst even before takeoff
Pfizer shot halts severe illness, why vaccinated people are getting 'breakthrough' infections, and other pandemic-related news across the globe
Pfizer, BioNTech join halting effort to produce covid-19 vaccines in Africa
Drugmakers face growing pressure from U.S., Europe to address global vaccine inequity
PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30, 2021.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, July 28, 2021, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Wednesday, June 30, 2021 (close of business) till 48 hours after the results are made public on July 28, 2021. We request you to kindly take the same on record.
Here is what real world evidence says about the efficacy of COVID-19 jabs against Delta variant
Pfizer-BioNTech, Moderna and AstraZeneca vaccines underwent clinical trials when Delta variant didn't exist.
Big Pharma's COVID-19 reputation boost may not last here's why
Over the past few months, the world has witnessed rapid clinical trials and approvals of several highly effective vaccines like Pfizer, Moderna and AstraZeneca. This unprecedented achievement has been made possible by close intra-industry, state industry and international collaborations. Pfizer Ltd - 500680 - Shareholding for the Period Ended June 30, 2021
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 031310 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated July 10, 2021, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2021.